SecBot SecBot
SECBOTREPLAY Home › Report › GMAB

GMAB · Insider sales disclosed

GENMAB A/S · 6-K filed Nov 12, 2026 at 08:45 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Nov 12, 2026 at 08:45 ET

Genmab filed a Form 6-K disclosing insider share transactions by the CEO, CFO, Chief Development Officer, Chief People Officer, and several board members on November 10, 2026. The CEO sold 22,000 shares at an average price of DKK 3,633.75, reducing his holding from 668,024 to 646,024 shares. The CFO sold 2,100 shares. Two board members exercised warrants to subscribe for shares. This is a routine regulatory disclosure of insider trades, not a periodic results release.

  • CEO Jan van de Winkel sold 22,000 shares at avg DKK 3,633.75 on Nov 10, 2026, reducing holding from 668,024 to 646,024 shares.
  • CFO Anthony Pagano sold 2,100 shares at avg DKK 3,670.29 on Nov 10, 2026.
  • EVP & Chief Development Officer Judith Klimovsky sold 1,265 shares at avg DKK 3,634.01.
  • EVP & Chief People Officer Christopher Cozic sold 3,854 shares at avg DKK 3,667.20.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access